NovoRapid is a brand name for insulin aspart, a fast-acting insulin analog used to control high blood sugar in individuals with diabetes mellitus. It is designed to mimic the insulin response of a healthy pancreas, particularly after meals, by rapidly absorbing into the bloodstream and starting to work within minutes of injection. This rapid onset allows for closer timing with meal consumption, helping to manage blood sugar spikes that occur after eating. NovoRapid is typically administered via injection just before or soon after mealtime. It is used by people with type 1 diabetes, who produce no insulin, and by some people with type 2 diabetes, whose bodies do not use insulin effectively. Managing blood sugar levels with medications like NovoRapid is crucial in preventing the long-term complications of diabetes, such as damage to the eyes, kidneys, and nerves.